期刊文献+

口含低剂量干扰素α的免疫调节作用 被引量:2

Immunoregulatory effect of oral low dose interferon α
原文传递
导出
摘要 Ⅰ型干扰素α(Interferon α,IFNα)和β(Interferon β,IFNβ)除了具有较强的抗病毒作用外,在对自身或外来抗原的免疫调节中也起着重要作用。本文对口含低剂量IFNα在局部和系统免疫调节中的作用作一综述。 As molecules with powerful antiviral activity,interferons α and β play critical roles in modulating immune responses to foreign and self-antigens.This paper reviews the role of oral low dose IFNα in local and systemic immunoregulation.
作者 王妍 蒋为民
出处 《中国生物制品学杂志》 CAS CSCD 2012年第9期1234-1236,共3页 Chinese Journal of Biologicals
基金 2009年深圳市科信贸局科技三新项目(JAS2009032012-00A)
关键词 干扰素Α 口含片剂 免疫调节 Interferon α Buccal tablet Immunoregulation
  • 相关文献

参考文献18

  • 1Smiatacz T,Zielińska W.Does hepatitis B virus or hepatitis C virusinfection influence CD4 count in HIV-positive individuals[J].Arch Immunol Ther Exp(Warsz),1996,44(5-6):335-343.
  • 2Russell IJ,Michalek JE,Kang YK,et al.Reduction of morningstiffness and improvement in physical function in fibromyalgia syn-drome patients treated sublingually with low doses of human inter-feron-α[J].J Interferon Cytokine Res,1999,19(8):961-968.
  • 3Sugawara S.Interleukin-18 and oral mucosal immunity[J].Int CongSer,2005,1284:113-122.
  • 4Cummins JM,Beilharz MW,Krakowka S.Oral use of interferon[J].J Interferon Cytokine Res,1999,19(8):853-857.
  • 5De-Gennaro LA,Popi AF,Almeida SR,et al.B-1 cells modulate o-ral tolerance in mice[J].Immunol Lett,2009,124(2):63-69.
  • 6Yuen MF,Lai CL.Treatment of chronic hepatitis B[J].Lancet In-fect Dis,2001,1(4):232-241.
  • 7Lapiński TW,Dabrowska MM.Activity of cytokines in chronicHCV-infected patients[J].Przegl Epidemiol,2007,61(4):747-754.
  • 8张琳,苗亮,韩峰,窦晓光.慢性丙型肝炎患者血清细胞因子水平的变化及意义[J].细胞与分子免疫学杂志,2011,27(3):301-303. 被引量:7
  • 9Zielińska W,Korczak-RogońA,Paszkiewicz J,et al.Comparison ofthe long-term effects of treatment with oral and parenteral interfer-on alpha in chronic viral hepatitis patients[J].Arch Immunol TherExp(Warsz),1996,44(5-6):359-366.
  • 10仉洪田,田庚善,徐国柱,张平清,黄德龙.口含干扰素治疗慢性乙型肝炎临床疗效观察[J].临床肝胆病杂志,1997,13(2):90-92. 被引量:12

二级参考文献31

  • 1江载芳,胡亚美.实用儿科学.人民卫生出版社,2003,2.
  • 2贾平,孟庆仁,等.中国实用医药研究.北京科技出版社,1998:329-330.
  • 3容建材.新编药理学.江苏科学技术出版社,1990:584.
  • 4王木昆 王恒永 等.口服干扰素治疗秋季腹泻32例[J].山东医药,1994,2.
  • 5Lapifiski TW, Dabrowska MM. Activity of cytokines in chronic HCV- infected patients[J]. Przegl Epidemiol, 2007, 61 (4) : 747 -754.
  • 6Falasca K, Mancino P, Ucciferri C. Inflammatory cytokines and S100b protein in patients with hepatitis C infection and cryoglobulinemias[J]. Clin Invest Med, 2007, 30(5) : E167 -176.
  • 7Sobchak DM, Korochkina OV. Cytokine regulation of immune response in patients with acute HCV infection [ J ]. Ter Arkh, 2005,77 (11) : 23 -29.
  • 8Trapero M, García-Buey L, Munoz C, et al. Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controis viral replication in genotype-1 patients with chronic hepatitis C [J]. Rev Esp Enferm Dig, 2005, 97(7) : 481 -490.
  • 9Masaki N, Fukushima S, Hayashi S. Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C[ J ]. Dig Dis Sci, 2002, 47 (10) : 2163 - 2169.
  • 10Lee CH, Choi YH, Yang SH, et al. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activatedmacrophages [ J]. Virology, 2001, 279 ( 1 ) : 271 - 279.

共引文献22

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部